Aditya Birla Sun Life NIFTY Healthcare ETF
Holdings
21
Concentrated
Top 10 weight
76%
Concentration
Strategy
Index
Passive exposure
Equity
99%
Asset allocation
Portfolio
2Sectors
8Large positions
78.8%Top: Pharmaceuticals & Biotechnology
0.9%Cash
Market-cap allocation
Large cap61%
Mid cap37%
Small cap2%
Asset allocation
Equity99%
Cash1%
Top holdings
18.2%
8.1%
8.0%
7.6%
Cipla LimitedEQUITY
7.5%6.9%
Lupin LimitedEQUITY
5.3%Laurus Labs LimitedEQUITY
5.1%4.6%
4.4%
Aurobindo Pharma LimitedEQUITY
3.8%3.3%
3.1%
Biocon LimitedEQUITY
2.9%2.6%
Mankind Pharma LtdEQUITY
2.6%2.0%
Abbott India LimitedEQUITY
1.3%Piramal Pharma LtdEQUITY
1.0%0.80%
AI Smart summary
Portfolio read
- 99% equity.
- Passive index strategy; portfolio differences should primarily reflect index tracking and cash management.
- Largest equity sector is Pharmaceuticals & Biotechnology at 78.8% of the portfolio.
- Large-cap exposure is 61%.
Watchpoints
- Compact 21-position portfolio; each large position can materially affect returns.
- Top 10 positions account for 76%, indicating high portfolio concentration.
- Sector concentration is elevated: Pharmaceuticals & Biotechnology represents 79%.
Auto-generated from fund metrics. Educational only - not investment advice.
Peer comparison
Similar index portfolios by equity allocation and concentration.
NIPPON INDIA ETF NIFTY 50 VALUE 20 (A Open Ended Index Exchange Traded Fund)22 holdings · 76% top 10
HDFC Nifty50 Value 20 ETF21 holdings · 76% top 10
Nippon India Nifty 50 Value 20 Index Fund22 holdings · 76% top 10
ICICI Prudential Nifty50 Value 20 ETF21 holdings · 76% top 10
Kotak Nifty 50 Value 20 ETF21 holdings · 76% top 10
ICICI Prudential Nifty50 Value 20 Index Fund22 holdings · 76% top 10
Sector exposure
Full industry / sector breakdown aggregated from the fund's holdings.
78.8%
20.3%